SYMBOL THERAPEUTICS
Symbol Therapeutics is a drug discovery company developing a novel immunoregulatory therapeutic protein. Their proprietary modified protein is able to activate anti-inflammatory regulatory mechanisms and thereby restore normal immune homeostasis.
SYMBOL THERAPEUTICS
Industry:
Biotechnology Life Science Therapeutics
Founded:
2021-01-01
Status:
Active
Similar Organizations
Amorsa Therapeutics, Inc.
Amorsa is developing treatments for neuropsychiatric disorders.
Migra Therapeutics
Migra Therapeutics is developing nanotechnology therapies for cancer.
Neos Therapeutics
Neos Therapeutics is an oral drug delivery company developing controlled time-release technologies.
NK:IO
NK:IO is a biotech company that develops novel approaches to natural killer cell-mediated immunotherapy.
Proviva Therapeutics
Proviva Therapeutics is a pro-drug design platform for cytokines and other fusion proteins.
VOCSense
VOCSens spin-off is developing a new concept of an environmental camera.
Current Advisors List
Current Employees Featured
More informations about "Symbol Therapeutics"
Symbol Therapeutics 2025 Company Profile: Valuation, …
Symbol Therapeutics General Information Description. Developer of novel immunoregulatory therapeutic protein designed for the treatment of autoimmune diseases. The company's proprietary modified protein is able to activate anti …See details»
Symbol Therapeutics - Crunchbase Company Profile & Funding
Symbol Therapeutics is a drug discovery company developing a novel immunoregulatory therapeutic protein. Their proprietary modified protein is able to activate anti-inflammatory …See details»
Symbol Therapeutics - Israeli Startup | Startup Nation Finder
Work Email* (please provide your email in the organization) Position* Notes. Send Create Free Account. Create Free Account. 8 Characters, Uppercase letter (A-Z), Lowercase letter (a-z), …See details»
Symbol Therapeutics - RMGLOBAL HEALTHCARE FUND …
Symbol Therapeutics is developing a modified therapeutic protein to enhance immune regulation in autoimmune diseases. Scientific approach. Semaphorin3A is a protein involved in immune regulation, in addition to other functions. The …See details»
Symbol Therapeutics - Drug pipelines, Patents, Clinical trials
100 Translational Medicine associated with Symbol Therapeutics. Login to view more data. Corporation Tree. Boost your research with our corporation tree data. login. or. view full …See details»
Symbol Therapeutics Ltd.: Drug pipelines, Patents, Clinical trials ...
Jun 30, 2023 Explore Symbol Therapeutics Ltd. with its drug pipeline, therapeutic area, technology platform, .See details»
Symbol Therapeutics is hiring! Symbol Tx is seeking a highly …
Symbol Therapeutics is hiring! Symbol Tx is seeking a highly talented and motivated individual to join us as a Research Scientist. Symbol Tx is a FutuRx portfolio drug discovery company ...See details»
Symbol Therapeutics Ltd / SYMBOL THERAPEUTICS LTD - 516495587
Information about company SYMBOL THERAPEUTICS LTD - 516495587 Ramon Ilan 2 ,Nes ZionaSee details»
Yefim Pen - Symbol Therapeutics - LinkedIn
Highly motivated Ph.D. scientist with more than 10 years of research activity in the… · Experience: Symbol Therapeutics · Education: Weizmann Institute of Science · Location: …See details»
Symbol Therapeutics - Crunchbase
Symbol Therapeutics is a drug discovery company developing a novel immunoregulatory therapeutic protein.See details»
Symbol Therapeutics - Suggested Companies | Startup Nation Finder
Modified Protein for Treatment of Autoimmune DiseasesSee details»
Symbol Therapeutics - 药物管线_专利_临床试验_投融营收
了解Symbol Therapeutics公司的药物管线，治疗领域，技术平台，以及它的。See details»
Symbol Therapeutics - Modified Protein for Treatment of …
Find out more about Symbol Therapeutics's founders and team members at Start-Up Nation Finder!See details»
Symbol Glossary - Heron Therapeutics
Dec 3, 2024 Feb 27 2025 - Heron Therapeutics Announces Fourth Quarter and Full-Year 2024 Financial Results ... Matched Rewrite Query: pagename=symbol_glossary&page= Loaded …See details»
2025-0106– Name and Symbol Change - GeneTether Therapeutics …
Le 10 janvier/January 2025 GeneTether Therapeutics Inc. (GTTX) has announced a name and symbol change to Rize Oncology Inc. (RIZE) Shares will begin trading under the new name …See details»
Structure Therapeutics Announces Selection of Lead Oral Small …
Dec 17, 2024 Structure Therapeutics is developing a series of both DACRAs and SARAs, as both approaches have demonstrated potential as obesity and chronic weight management …See details»
Canadian Investment Regulatory Organization Trading Halt - ATE
Apr 9, 2024 TSX Symbol: ATE. All Issues: Yes. Reason: Dissemination. Halt Time (ET): 9:15 AM CIRO can make a decision to impose a temporary suspension (halt) of trading in a security of …See details»
Symbol Therapeutics - Contacts, Employees, Board Members
Symbol Therapeutics has 4 current employee profiles, including CSO Adi Sagiv. Symbol Therapeutics has 2 board members and advisors, including Elias Toubi . ContactsSee details»
Biotech Stock Soleno Therapeutics Skyrockets On Obesity-Tied …
2 days ago Soleno Therapeutics plans to charge $486,000 a year for patients who weigh between 40 and 65 kilograms. ... Real-time quote and/or trade prices are not sourced from all …See details»
SLNO Stock Rallies on FDA Approval of Prader-Willi Syndrome Drug
2 days ago In the past 30 days, the estimate for Corcept Therapeutics’ 2025 earnings per share has increased from $1.85 to $1.87. The estimate for 2026 earnings per share has remained …See details»